In Wha Pharmaceutical Co., Ltd.
South KoreaFDA applicant, unverified
- Devices
- 1
What In Wha Pharmaceutical Co., Ltd. makes
In Wha Pharmaceutical Co., Ltd. manufactures the UROTEST GPH, a diagnostic device used for detecting urinary tract infections or assessing urinary tract health through specific test methods.
The UROTEST GPH is classified as a Class II medical device in the U.S. and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
Urotest Gph Ref K912244
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does In Wha Pharmaceutical Co., Ltd. have in the registry?
The registry currently lists 1 device for In Wha Pharmaceutical Co., Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list In Wha Pharmaceutical Co., Ltd.'s devices?
Among its 1 most recently registered device, In Wha Pharmaceutical Co., Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do In Wha Pharmaceutical Co., Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for In Wha Pharmaceutical Co., Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from In Wha Pharmaceutical Co., Ltd. in the registry?
The most recently registered devices listed for In Wha Pharmaceutical Co., Ltd. include UROTEST GPH.